Primary Versus Secondary Failure After Varicella Vaccination
- 1 July 2013
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 32 (7) , e305-e313
Abstract
Background: Two-dose varicella vaccination is recommended for optimal control of varicella in populations with high (>90%) 1-dose coverage. Optimal timing of the second dose may depend on whether breakthrough varicella results from primary vaccine failure (no protective immunity after vaccination) or secondary vaccine failure (waning protective immunity). Methods: Published literature (1995 to 2012) on vaccine failure after varicella vaccination cited in PubMed and other online sources was reviewed. Results: Nineteen publications detailed 21 varicella outbreaks with breakthrough varicella rates ranging from 0% to 42%; the publications showed no consistent trend between breakthrough varicella rate and time since vaccination. Conclusions: Literature to date indicates a relatively high rate of primary vaccine failure and limited evidence of secondary vaccine failure among 1-dose varicella vaccine recipients, suggesting that a short interval between 2 doses might be preferable in countries considering implementation of universal varicella vaccination to reduce breakthrough varicella. However, any potential disruption to well-established vaccination schedules should be considered.Keywords
This publication has 98 references indexed in Scilit:
- An Outbreak of Varicella among Schoolchildren in TaipeiBMC Public Health, 2011
- Effectiveness of 2 Doses of Varicella Vaccine in ChildrenThe Journal of Infectious Diseases, 2011
- Complications of Varicella After Implementation of Routine Childhood Varicella Vaccination in GermanyThe Pediatric Infectious Disease Journal, 2010
- Incremental Effectiveness of Second Dose Varicella Vaccination for Outbreak Control at an Elementary School in Philadelphia, Pennsylvania, 2006The Pediatric Infectious Disease Journal, 2010
- Decline in Varicella-Related Ambulatory Visits and Hospitalizations in the United States Since Routine Immunization Against VaricellaThe Pediatric Infectious Disease Journal, 2010
- Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro®) and a varicella vaccine (VARIVAX®) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trialBMC Medicine, 2009
- Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005Archives of Disease in Childhood, 2008
- Primary Vaccine Failure after 1 Dose of Varicella Vaccine in Healthy ChildrenThe Journal of Infectious Diseases, 2008
- Varicella Vaccine Effectiveness in the US Vaccination Program: A ReviewThe Journal of Infectious Diseases, 2008
- Decline in Mortality Due to Varicella after Implementation of Varicella Vaccination in the United StatesNew England Journal of Medicine, 2005